USD 41.32
(1.63%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 | - ZAR | 0.0% |
2023 | 2.15 Billion ZAR | 3.1% |
2022 | 2.08 Billion ZAR | 5.66% |
2021 | 1.97 Billion ZAR | 10.06% |
2020 | 1.79 Billion ZAR | 830.72% |
2019 | 192.89 Million ZAR | -4.57% |
2018 | 202.13 Million ZAR | 4.72% |
2017 | 193.02 Million ZAR | 1.37% |
2016 | 190.4 Million ZAR | 5.51% |
2015 | 180.46 Million ZAR | 7.2% |
2014 | 168.34 Million ZAR | 11.04% |
2013 | 151.6 Million ZAR | 7.48% |
2012 | 141.05 Million ZAR | 742305.26% |
2011 | 19 Thousand ZAR | -99.89% |
2010 | 16.57 Million ZAR | -55.7% |
2009 | 37.42 Million ZAR | -39.1% |
2008 | 61.46 Million ZAR | -20.88% |
2007 | 77.68 Million ZAR | -48.51% |
2006 | 150.85 Million ZAR | -10.04% |
2005 | 167.68 Million ZAR | -35.44% |
2004 | 259.73 Million ZAR | -37.04% |
2003 | 412.53 Million ZAR | 78.94% |
2002 | 230.54 Million ZAR | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q2 | 2.53 Billion ZAR | -100.0% |
2024 Q4 | - ZAR | 0.0% |
2024 Q1 | 2.53 Billion ZAR | 0.0% |
2023 Q4 | 2.15 Billion ZAR | 0.0% |
2023 Q1 | 2.18 Billion ZAR | 4.63% |
2023 FY | 2.15 Billion ZAR | 3.1% |
2023 Q3 | 2.15 Billion ZAR | -1.46% |
2023 Q2 | 2.18 Billion ZAR | 0.0% |
2022 Q3 | 2.08 Billion ZAR | -5.98% |
2022 Q4 | 2.08 Billion ZAR | 0.0% |
2022 FY | 2.08 Billion ZAR | 5.66% |
2022 Q1 | 2.22 Billion ZAR | 12.37% |
2022 Q2 | 2.22 Billion ZAR | 0.0% |
2021 FY | 1.97 Billion ZAR | 10.06% |
2021 Q1 | 1.95 Billion ZAR | 8.8% |
2021 Q2 | 1.95 Billion ZAR | 0.0% |
2021 Q3 | 1.97 Billion ZAR | 1.16% |
2021 Q4 | 1.97 Billion ZAR | 0.0% |
2020 Q2 | 1.73 Billion ZAR | 0.0% |
2020 Q1 | 1.73 Billion ZAR | 797.96% |
2020 FY | 1.79 Billion ZAR | 830.72% |
2020 Q3 | 1.79 Billion ZAR | 3.65% |
2020 Q4 | 1.79 Billion ZAR | 0.0% |
2019 Q2 | 198.92 Million ZAR | 0.0% |
2019 Q1 | - ZAR | -100.0% |
2019 FY | 192.89 Million ZAR | -4.57% |
2019 Q4 | 192.89 Million ZAR | -87.05% |
2019 Q3 | 1.48 Billion ZAR | 648.79% |
2018 Q2 | 198.69 Million ZAR | 0.0% |
2018 FY | 202.13 Million ZAR | 4.72% |
2018 Q4 | 202.13 Million ZAR | 0.0% |
2018 Q3 | - ZAR | -100.0% |
2018 Q1 | - ZAR | -100.0% |
2017 FY | 193.02 Million ZAR | 1.37% |
2017 Q4 | 193.02 Million ZAR | 0.0% |
2017 Q3 | - ZAR | -100.0% |
2017 Q2 | 184.08 Million ZAR | 0.0% |
2017 Q1 | - ZAR | -100.0% |
2016 Q1 | - ZAR | -100.0% |
2016 Q4 | 190.4 Million ZAR | 0.0% |
2016 Q2 | 186.55 Million ZAR | 0.0% |
2016 Q3 | - ZAR | -100.0% |
2016 FY | 190.4 Million ZAR | 5.51% |
2015 Q1 | - ZAR | -100.0% |
2015 Q2 | 176.91 Million ZAR | 0.0% |
2015 Q3 | - ZAR | -100.0% |
2015 Q4 | 180.46 Million ZAR | 0.0% |
2015 FY | 180.46 Million ZAR | 7.2% |
2014 FY | 168.34 Million ZAR | 11.04% |
2014 Q3 | - ZAR | -100.0% |
2014 Q4 | 168.34 Million ZAR | 0.0% |
2014 Q1 | - ZAR | -100.0% |
2014 Q2 | 160.8 Million ZAR | 0.0% |
2013 FY | 151.6 Million ZAR | 7.48% |
2013 Q3 | - ZAR | -100.0% |
2013 Q4 | 151.6 Million ZAR | 0.0% |
2013 Q2 | 146 Million ZAR | 0.0% |
2013 Q1 | - ZAR | -100.0% |
2012 FY | 141.05 Million ZAR | 742305.26% |
2012 Q4 | 141.05 Million ZAR | 0.0% |
2012 Q3 | - ZAR | 0.0% |
2012 Q2 | - ZAR | 0.0% |
2011 FY | 19 Thousand ZAR | -99.89% |
2011 Q4 | 19 Thousand ZAR | 0.0% |
2011 Q2 | 10.04 Million ZAR | 0.0% |
2010 FY | 16.57 Million ZAR | -55.7% |
2010 Q2 | 32.08 Million ZAR | 0.0% |
2010 Q4 | 16.57 Million ZAR | 0.0% |
2009 Q4 | 37.42 Million ZAR | 0.0% |
2009 FY | 37.42 Million ZAR | -39.1% |
2009 Q2 | 67.95 Million ZAR | 0.0% |
2008 FY | 61.46 Million ZAR | -20.88% |
2008 Q4 | 61.46 Million ZAR | 0.0% |
2007 FY | 77.68 Million ZAR | -48.51% |
2006 FY | 150.85 Million ZAR | -10.04% |
2005 FY | 167.68 Million ZAR | -35.44% |
2004 FY | 259.73 Million ZAR | -37.04% |
2003 FY | 412.53 Million ZAR | 78.94% |
2002 FY | 230.54 Million ZAR | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Alternative Energy Partners, Inc. | 312.15 Thousand USD | 100.0% |
Allstar Health Brands, Inc. | - USD | NaN% |
Beijing Tong Ren Tang Chinese Medicine Company Limited | 21.25 Thousand USD | 100.0% |
Café Serendipity Holdings, Inc. | - USD | NaN% |
Decision Diagnostics Corp. | - USD | NaN% |
Health Advance Inc. | 254.07 Thousand USD | 100.0% |
HealthWarehouse.com, Inc. | 2.63 Million USD | 100.0% |
LIGAND PHARMACEUTICAL INC | 5.75 Million USD | 100.0% |
MedGen, Inc. | - USD | NaN% |
Omni Health, Inc. | 495.57 Thousand USD | 100.0% |
Oxford Investments Holdings Inc. | - USD | NaN% |
Pineapple, Inc. | - USD | NaN% |
ScripsAmerica, Inc. | 1.06 Million USD | 100.0% |